
Eli Lilly falls on profit downgrade; drug sales surge
Eli Lilly reported better-than-expected first-quarter results Thursday, powered by surging demand for its weight loss and diabetes treatments. However, shares dropped 11.7% as the company cut its profit outlook for the year. It also faced a setback in …